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Abstract Tuberculin test (purified protein derivative) is currently accepted as a standard investigation used in the di-
agnosis of tuberculosis (TB). Although the sensitivity of the test is reliable, a substantial number of those subjected to
screening forTB by such test are cigarette smokers.This study is designed to investigate the effect of smoking on cell-
mediateddelayed-type cellularhypersensitivity (DTH) reactionby PPD.Prospective, case-control studywas conducted
atthe Chest and TB unit of Chest Hospital Kuwait.The study population consisted of 357 healthy volunteers serving as
controls and 200 in-patientsunderdirectmedical supervision andtreatmentfor tuberculosis as cases.Themean agewas
33.69 7 8.6 SD; 286 were current smokers and 271 were lifetime non-smokers. PPD test was done using 2TU RT23
SSIFDenmarkon all subjects.Median PPDwas significant among the cases (P=0.03) between smokers and non-smo-
kers andwashighly significant among thehealthycontrols (Po0.001).No significantdifferencewas seenbetweenmedian
pack years of smoking and PPDlevels among the patient group (P=0.264), butthe differencewas significant among the
controlgroup (Po0.001).Univariate analysisof variance (ANOVA) onPPD, takinginto accountage, packyearsof smoking,
ethnic groups and BCG scar showed sufficient response but was not statistically significantto all these factors. Smoking
habit does not appear to influence the cutaneous delayed type hypersensitivity reaction by tuberculin skin test.r 2003
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Smoking habit is still rampant worldwide, inspite of the
measures taken to reduce its negative impact socially
and ¢nancially on the community at large.Tuberculin test
(PPD test) is widely used as a diagnostic test for tubercu-
losis (TB). However, the test is invariably performed on
both smokers and non-smokers in suspected cases of tu-
berculosis regardless of their smoking habit. Although
the test is reliable and useful in the majority of cases,
smoking may be a factor e¡ecting its sensitivity. Ander-
son et al. (1) found that smokersweremore likely to have
become tuberculin skin test converters during incar-
ceration than non-smokers.Moszczynski (2) and Slovins-
ki (3) con¢rmed that there is a suppressing e¡ect of
cigarette smoke inhaled for a long time on cell-mediated
immunity in humans.Qvarfordtet al. (4) in their studyon
cutaneous delayed type hypersensitivity reaction among$Certi¢ed that this study was not funded.
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ing on delayed-type hypersensitivity reaction.
The aim of the present study was to investigate
whether smoking depresses cell-mediated immunity, by
cutaneous delayed hypersensitivity reaction, using PPD
test among patients on treatment of tuberculosis and
asymptomatic controls.
METHODS
Study population andprotocol
The cases were selected consecutively frompatients ad-
mitted to Chest Hospital Kuwait, for the initial phase of
treatment for pulmonary and extra pulmonary tubercu-
losis.Control population was drawn randomly from the
generalpopulation attendingroutineresidency screening
for employment in Kuwait. A detailed smoking history
and demographic characteristics were obtained by an
interviewer led questionnaire. After excluding active
pulmonary tuberculosis by history and chest radiograph,
the 2TU PPD Test (PPD-RT23 SS1, Statein Institute
Denmark) was administered to all in-patients with
tuberculosis and to controls. The test was read after
TABLE 1. Socio-demographic characteristics of cases
and controls
Cases n
(%)
Controls n
(%)
Totaln
(%)
Gender
Male 121(60.5) 352(98.6) 473(84.9)
Female 79(39.5) 5(1.4) 84(15.1)
Nationality
Kuwaiti 20(10.0) 7(2.0) 27(4.8)
Arab Non-Kuwaiti 28(14.0) 90(25.2) 118(21.2)
Asian 152(76.0) 253(70.8) 405(72.7)
Others F 7(2.0) 7(1.3)
Smoking status
Current smoker 87(43.5) 199(55.7) 286(51.3)
Non-smoker 113(56.5) 158(44.3) 271(48.7)
Presence of BCG scar
Yes 126(63.0) 204(57.1) 330(59.2)
No 74(37.0) 153(42.9) 227(40.8)
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are currently smoking cigarettes, pipes or cigars at
the time of the survey and non-smokers as lifetime non-
smokers.
Patients excluded were: 1FEx-smokers who had
smoked daily and given up smoking; 2FHIV patients;
and 3Fpatients who were immunosuppresed due to
long-term systemic steroids. A total of 665 subjects
were entered in this prospective study. The subjects
were categorized as current smokers and non-smokers;
as cases and controls. BCG status was assessed by the
presence or absence of BCG scar.
Statisticalmethods
The statistical software SPSS version 10.0 on windows
was used for data analysis (5). The descriptive statistics
F mean, standard deviation, median, and percentiles
were used to describe the ¢ndings. Since the PPD levels
showed a skewed distribution, Mann^Whitney test
was used to compare the di¡erence between two
groups. For more than two groups Kruskal^Wallis one-
way ANOVA was used. Univariate analysis of variance
was used to ¢nd the e¡ect of more than one factor
(smoking status, cases and controls, ethnic groups and
BCG status) on PPD levels. Since PPD as suchwas found
to be skewed, a suitable transformation (square root of
PPD + 2) was carried out before data were subjected to
univariate analysis.The value of Po0.05 is taken as level
of signi¢cance.
RESULTS
The study comprised of a total of 665 subjects, (228
cases and 437 controls). Sociodemographic characteris-
tics are shown inTable 1. After exclusion of ex-smokers
there were 200 cases and 357 controls. Mean age was
33.697 8.65 SD.Male-to-femaleratiowas1:0.15. Asianna-
tionals formed 72.7% followed by Arab non-Kuwaiti na-
tionals 21.2%, Kuwaiti nationals 4.8% and other nationals
1.3%. Current smokers were 286 and 271 were lifetime
non-smokers. The duration of abstinence from smoking
could not be quanti¢ed; so all the ex-smokers were ex-
cluded from the study.
Table 2 shows the median PPD values in millimeters,
2.5th and 97.5th percentile of PPD among the cases and
control population by the presence or absence of BCG
scar and smoking status. The median and 2.5th and
97.5th percentile of PPD in mm shows signi¢cant di¡er-
ence between smokers 18.0 (7.8, 24.2) and non-smokers
18.0 (0, 28.0), P=0.042 in the presence of BCG scar.This
di¡erence among the cases were not signi¢cant in the
absence of BCG scar16.0 (0, 24.0) in smokers and16.0 (0,
30.0) in non-smokers, P=0.344. In the case of controls,
signi¢cant di¡erence in PPD was noticed,14.0 (0, 20.0) in
smokers and11.0 (0,19.8) in non-smokers, Po0.001in thepresence of BCG scar and 12.0 (0, 19.0) in smokers and
10.5 (0, 20.0), P=0.006 in the absence of BCG scar.When
thegroup totalswere studied, the PPD levelswere signif-
icantly di¡erent,17.0 (0, 23.6) in smokers and18.0 (0, 30.0)
in non-smokers, P=0.034 among patients; and 13.0 (0,
20.0) in smokers and 11.0 (0, 20.0) in non-smokers,
Po0.001among controls.
Non-parametric correlation of PPD levels showed a
negative weak correlation with age, r=0.087, p=0.221
and with pack years of smoking, r=0.099, P=0.165 in
the patient group, which is not statistically signi¢cant.
While there is signi¢cant positive correlation of PPD le-
vel in the control group, r=0.386, Po0.001 for age and
r=0.323, Po0.001for pack years of smoking.
Table 3 shows themedian and 2.5th and 97.5th percen-
tile of pack years of smoking by the level of PPD in mm
among the cases and controls. For statistical analysis
PPD levels were divided into four groups, 0^5 mm, 6^10
mm, 11^15 mm and o15 mm. Among the patients the
median pack year of smoking showed an increase only
in the 11^15 mm PPD group, P=0.264. In the control
group there is signi¢cant di¡erence in the median pack
years of smoking to the PPD levels, Po0.001.
There is signi¢cantdi¡erence in themedian PPD levels
among the di¡erent nationalities, 16 (0,25) for Kuwaitis,
14 (0,24) for Arab non-Kuwaitis and13 (0,24) for Asians,
P=0.008.
Univariate analysis of variance (ANOVA) with trans-
formed values of PPD as dependent variable and subject
factorsFcases and controls, smokers and non-smokers,
presence or absence of BCG scar and ethinicity were
done to assess the interaction of various variables.
The e¡ect of smoking on the PPD levels were not
the same in the cases andcontrols,Po0.001for the inter-
action of two factors. This e¡ect of smoking on PPD
among the cases and controls were same when
674 RESPIRATORYMEDICINEpack-years of smoking is added as a covariate, P=0.076.
There is signi¢cant e¡ect of smoking among cases and
controlswhen age is added as covariate,Po0.001.The in-
teraction of three factors, cases and controls smoking
status and presence or absence of BCG scar shows no
signi¢cant e¡ect on the PPD level, P=0.793.The smoking
showed no signi¢cant e¡ect on PPD levels among cases
and controls when ethnicity was included, P=0.332.
When pack-years of smoking is added to the above,
still no signi¢cant interaction was seen between the
variables, P=0.906.TABLE 2. Median and Percentiles of PPD by the Pre-
sence of BCG Scar, Smoking Status Among the Cases
and Controls
PPDinmm
Smokers Non-smokers p-value*
Cases
Presence of BCG scar
Yes 18.0 (7.8, 24.2) 18.0 (0, 28.0) 0.042
n 56 70
No 16.0 (0, 24.0) 16.0 (0, 30.0) 0.344
n 31 43
Total 17.0 (0, 23.6) 18.0 (0, 30.0) 0.034
87 113
Controls
Presence of BCG scar
Yes 14.0 (0, 20.0) 11.0 (0,19.8) 40.001
n 122 82
No 12.0 (0,19.0) 10.5 (0, 20.0) 0.006
n 77 76
Total 13.0 (0, 20.0) 11.0 (0, 20.0) 40.001
199 158
*Smokers vs Non-smokers by Mann-Whitney test.
Data are median (2.5th and 97.5th percentiles). n=num-
ber.
TABLE 3. Median andpercentiles of pack-years of smoking, byl
PPDin
0^5 6^10
Cases
n 9 14
Pack-year 0 (0,15) 0 (0,8)
Controls
n 85 35
Pack-year 0 (0,13.8) 0 (0, 34)
Data aremedian (2.5th and 97.5th percentiles). * Kruskal-WalDISCUSSION
It is now evident that the total IgE shows elevated levels
in relation to active smoking in the general population
and asthmatic smokers. Although there are di¡erences
between the aetiologies of TB and asthma as separate
entities, smoking in general seems to alter a variety
of blood components with major impact on the func-
tional responses of haemopoeitic origin. (6^14) The
question posed in this study, is whether the cell
mediated delayed-type cellular hypersensitivity (DTH)
reaction by tuberculin test is a¡ected by smoking, as tu-
berculin test is a delayed type of hypersensitivity re-
sponse that shows cutaneous reaction to PPD as a
manifestation of cell-mediated immunity. (15^17) After
exclusion of ex-smokers, cases , and controls were cate-
gorized as current smokers and non-smokers, some in-
teraction was seen among the cases, (P=0.042) and
(P=0.344) in thepresence or absence of BCG scar. Signif-
icant interaction between PPD and smoking status was
seen among the control group (Po0.001 and P=0.006).
The PPD diameter in mm was less in the non-smoker
group when compared to smokers in the control group,
Po0.001. Smoking status showed less in£uence on the
PPD reading,P=0.034, among patients with active tuber-
culosis.
It is evident from this study that smokers have higher
PPD value when compared to non-smokers in the con-
trol group, while PPD values were higher among the
non-smokers compared to smokers in the patient
group. If smoking in£uences the delayed-typehypersensi-
tivity reaction, the PPD values would have shown
decreasing values among the cases and controls in smo-
kers compared to non-smokers which is not the case
in this study.Qvarfordtetal. (4) in his studyon cutaneous
delayed type hypersensitivity reaction in smokers
with chronic bronchitis and recurrent exacerbation,
in comparison with asymptomatic smokers and never
smokers found no in£uence of smoking status on DTHevel of PPDamongcases and controls
mm
11^15 415 P-value*
42 135
2.38 (0, 38.38) 0 (0, 29.42) 0.264
167 70
1.2 (0, 29.25) 4.13 (0, 30) o0.001
lis test. n=number
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bronchitis did not di¡er from asymptomatic smokers
and healthy never smokers with respect to DTH reac-
tion. (4,18)
The control group in this present study comprised
mainly the expatriate population (71.7% are Asians and
Arab non-Kuwaiti nationals 21.5%) and they are from
areas with high endemicity for tuberculosis.Thismay ex-
plain the higher PPD value, of smokers among the con-
trol population. The e¡ect of BCG on tuberculin test
among general population is controversial. (19^21) In this
study the presence or absence of BCG scar which indi-
cate previous sensitization to tuberculo-protein, showed
more signi¢cant di¡erence in the control group. Larger
studies are required to validate this ¢nding. Although
PPD levels vary according to ethnicity, no signi¢cant ef-
fect was seen in the interaction of ethnicity over smok-
ing status among cases and controls.
Anderson et al. (1) suggests that cumulative e¡ect of
smokingmay bemore important than the number of ci-
garettes smoked with regard to tuberculin test conver-
sion. The pack years of smoking indirectly indicate the
cumulative e¡ect of smoking on the defense mechan-
isms. In this study no statistically signi¢cant suppression
of tuberculin reaction was seen in relation to pack years
of smoking.Nissaretal. (22) showed that tuberculinHeaf
test positivity was stronger in smokers (OR=1.59) than
ex-smokers (OR=1.20) and with reference to non-smo-
kers. Planet et al. (23) showed that a positive tuberculin
testwas associatedwith duration of smoking (OR=1.03^
1.12 per year) and the proposed mechanism was an in-
creased susceptibility to mycobacterial infection among
smokers. Similar association is seen only in the control
group but not in the patients group in the present study.
This study is unique in that we compared the e¡ect of
smoking on tuberculin test both among healthy controls
and patients with tuberculosis.
In conclusion, smoking habit is still rampant in the
community and tuberculin test is used as a standard test
for diagnosis of tuberculosis. In our study, smoking did
not in£uence the delayed-type cutaneous hypersensitiv-
ity reaction in patients with tuberculosis and healthy
control subjects. Ideally, based on these ¢ndings, a large
prospective study is needed to verify and elucidate the
association between smoking and tuberculin skin test
conversion.
REFERENCES
1. Anderson RH, Sy FS, Thompson S, Addy C. Cigarette smoking and
tuberculin skin test conversion among incarcerated adults. Am J
Prev Med 1997; 13: 175–181.2. Moszczynski P, Slowinski S. Cell-mediated immunity in cigarette
smokers. Wiad Lek 1990; 43: 127–130.
3. Slovin’ski S, Moshchin’ski P. Cellular immunity in cigarette
smokers. Lab Delo 1989; 9: 55–58.
4. Qvarfordt I, Riise GC, Larsson S, Almqvist G, Rollof J. Cutaneous
delayed-type hypersensitivity reactions in smokers with chronic
bronchitis and recurrent exacerbations: comparison with asympto-
matic smokers and never-smokers. Respir Med 1999; 93: 491–497.
5. SPSS, Statistical Package for Social Sciences. User’s guide, release
10.0, New York: McGraw-Hill, 2000.
6. Miller LG, Goldstein G, Murphy M, Ginns LC. Reversible alterations
in immunoregulatory T cells in smoking. Analysis by monoclonal
antibodies and flow cytometry. Chest 1982; 82: 526–529.
7. Petersen BH, Steimel LF, Callaghan JT. Suppression of mitogen-
induced lymphocyte transformation in cigarette smokers. Clin Im-
munol Immunopathol.1983;27: 135–140.
8. Ferson M, Edwards A, Lind A, Milton GW, Hersey P. Low natural
killer-cell activity immunoglobulin levels associated with smoking in
humen subjects. Int J Cancer 1979; 23: 603–609.
9. Phillips B, Marshall ME, Brown S, Thompson JS. Effect of smoking
on human natural killer cell activity. Cancer 1985; 56: 2789–292.
10. Fietta A, Bersani C, De Rose V, et al. Evaluation of systemic host
defense mechanisms in chronic bronchitis. Respiration 1988; 53: 37–43.
11. Nielsen H, Bonde J. Association of defective monocyte chemotaxis
with recurrent acute exacerbations in chronic obstructive lung
disease. Eur J Respir Dis 1986; 68: 200–206.
12. Vecchiarelli A, Dottorini M, Puliti M, Todisco T, Cenci E, Bistoni F.
Defective candidacidal activity of alveolar macrophages and
peripheral blood monocytes from patients with chronic obstruc-
tive pulmonary disease. Am Rev Respir Dis 1991; 143: 1049–1054.
13. Schonfeld N, Remy N, Bartmann P, Wahn U, Loddenkemper R. In
vitro studies of cellular immunity in chronic bronchitis with and
without corticosteroid medication. Pneumologie 1992; 46: 179–
182.
14. Omenaas E, Jentoft HF, Vollmer WM, Buist AS, Gulsvik A.
Absence of relationship between tuberculin reactivity and atopy in
BCG vaccinated young adults. Thorax 2000; 55: 454–458.
15. Huebner RE, Schein MF, Bass Jr JB. The tuberculin skin test. Clin
Infect Dis 1993; 17: 968–975.
16. Villarino ME, Brennan MJ, Nolan CM, et al. Comparison testing of
current (PPD-S1) and proposed (PPD-S2) reference tuberculin
standards. Am J Respir Crit Care Med 2000; 161: 1167–1171.
17. Snider Jr DE. The tuberculin skin test. AmRev Respir Dis 1982; 125:
108–118.
18. Qvarfordt I, Riise GC, Larsson S, et al. Immunological findings in
blood and bronchoalveolar lavage fluid in chronic bronchitis
patients with recurrent infectious exacerbations. Eur Respir J 1998;
11: 46–54.
19. Menzies R, Vissandjee B. Effect of bacille Calmette–Guerin
vaccination on tuberculin reactivity. Am Rev Respir Dis 1992; 145:
621–625.
20. Menzies R, Vissandjee B, Rocher I, St Germain Y. The booster
effect in two-step tuberculin testing among young adults in
Montreal. Ann Intern Med 1994; 120: 190–198.
21. Horwitz O, Bunch-Christensen K. Correlation between tuberculin
sensitivity after 2 months and 5 years among BCG vaccinated
subjects. Bull World Health Organ 1972; 47: 49–58.
22. Nisar M, Williams CS, Ashby D, Davies PD. Tuberculin testing in
residential homes for the elderly. Thorax 1993; 48: 1257–1260.
23. Plant AJ, Watkins RE, Gushulak B, et al. Predictors of tuberculin
reactivity among prospective Vietnamese migrants: the effect of
smoking. Epidemiol Infect 2002; 128: 37–45.
